Equities

Precision BioSciences Inc

Precision BioSciences Inc

Actions
  • Price (EUR)8.65
  • Today's Change-0.45 / -4.95%
  • Shares traded10.00
  • 1 Year change-25.69%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Precision BioSciences Inc grew revenues 94.15% from 25.10m to 48.73m while net income improved from a loss of 111.64m to a smaller loss of 61.32m.
Gross margin--
Net profit margin18.02%
Operating margin-8.32%
Return on assets9.09%
Return on equity29.04%
Return on investment12.24%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Precision BioSciences Inc fell by 72.90m. However, Cash Flow from Investing totalled 5.83m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 84.11m for operations while cash generated from financing totalled 5.39m.
Cash flow per share4.20
Price/Cash flow per share3.32
Book value per share10.49
Tangible book value per share10.44
More ▼

Balance sheet in USDView more

Precision BioSciences Inc has a Debt to Total Capital ratio of 23.14%.
Current ratio4.37
Quick ratio--
Total debt/total equity0.3011
Total debt/total capital0.2314
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.